ScoreWhy is Zhejiang Huahai Pharmaceutical Co., Ltd. ?
1
Poor Management Efficiency with a low ROCE of 9.81%
- The company has been able to generate a Return on Capital Employed (avg) of 9.81% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 5.98% and Operating profit at -22.65% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 11.11% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 5.98% and Operating profit at -22.65% over the last 5 years
4
The company has declared positive results in Jun'2026 after 4 consecutive negative quarters
- NET PROFIT(Q) At CNY 362.79 MM has Grown at 249.09%
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
- INVENTORY TURNOVER RATIO(HY) Highest at 1.18 times
5
With ROE of 3.01%, it has a very expensive valuation with a 2.13 Price to Book Value
- Over the past year, while the stock has generated a return of -30.10%, its profits have fallen by -73.6%
- At the current price, the company has a high dividend yield of 2.4
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Zhejiang Huahai Pharmaceutical Co., Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Zhejiang Huahai Pharmaceutical Co., Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Zhejiang Huahai Pharmaceutical Co., Ltd.
-26.09%
-0.18
37.04%
China Shanghai Composite
3.23%
0.23
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
5.98%
EBIT Growth (5y)
-22.65%
EBIT to Interest (avg)
4.77
Debt to EBITDA (avg)
3.64
Net Debt to Equity (avg)
0.60
Sales to Capital Employed (avg)
0.52
Tax Ratio
34.81%
Dividend Payout Ratio
55.56%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.41%
ROE (avg)
11.11%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
71
Industry P/E
Price to Book Value
2.13
EV to EBIT
76.42
EV to EBITDA
24.61
EV to Capital Employed
1.65
EV to Sales
3.29
PEG Ratio
NA
Dividend Yield
2.43%
ROCE (Latest)
2.16%
ROE (Latest)
3.01%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend20What is working for the Company
NET PROFIT(Q)
At CNY 362.79 MM has Grown at 249.09%
INTEREST COVERAGE RATIO(Q)
The company hardly has any interest cost
INVENTORY TURNOVER RATIO(HY)
Highest at 1.18 times
NET SALES(Q)
Highest at CNY 2,577.44 MM
OPERATING PROFIT(Q)
Highest at CNY 760.63 MM
OPERATING PROFIT MARGIN(Q)
Highest at 29.51 %
PRE-TAX PROFIT(Q)
Highest at CNY 485.35 MM
-2What is not working for the Company
INTEREST(9M)
At CNY 179.62 MM has Grown at 7.25%
Here's what is working for Zhejiang Huahai Pharmaceutical Co., Ltd.
Pre-Tax Profit
At CNY 485.35 MM has Grown at 298.58%
over average net sales of the previous four periods of CNY 121.77 MMMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Profit
At CNY 362.79 MM has Grown at 249.09%
over average net sales of the previous four periods of CNY 103.92 MMMOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Net Sales
Highest at CNY 2,577.44 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Net Sales
At CNY 2,577.44 MM has Grown at 20.53%
over average net sales of the previous four periods of CNY 2,138.49 MMMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Operating Profit
Highest at CNY 760.63 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (CNY MM)
Operating Profit Margin
Highest at 29.51 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
Highest at CNY 485.35 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (CNY MM)
Inventory Turnover Ratio
Highest at 1.18 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its inventory faster
Inventory Turnover Ratio
Depreciation
Highest at CNY 275.97 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (CNY MM)
Depreciation
At CNY 275.97 MM has Grown at inf%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (CNY MM)
Here's what is not working for Zhejiang Huahai Pharmaceutical Co., Ltd.
Interest
At CNY 179.62 MM has Grown at 7.25%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Footer loading
